HIV Vaccines
HIV Vaccines
May 18 is National HIV Vaccine Awareness Day
- Details
- Category: HIV Vaccines
- Published on Tuesday, 17 May 2011 04:56
- Written by Liz Highleyman
Wednesday marks the 14th annual observance of National HIV Vaccine Awareness Day, calling attention to advances in vaccine research.
GeoVax and HIV Trials Network To Test Prime-Boost Vaccine
- Details
- Category: HIV Vaccines
- Published on Friday, 22 April 2011 22:05
- Written by GeoVax
GeoVax Labs this month announced that it will test a novel recombinant HIV prevention vaccine that showed promise in monkeys, in collaboration with NIAID and the HIV Vaccine Trials Network.
Vaccine Used in STEP Trial Alters HIV Genes
- Details
- Category: HIV Vaccines
- Published on Tuesday, 29 March 2011 01:35
- Written by University of Washington
The adenovirus vaccine candidate used in the STEP trial did not significantly reduce HIV infection, but did alter the genetic makeup of the virus, according to a recent report in Nature Medicine. 
HIV Envelope Discovery Could Reveal New Vaccine Targets
- Details
- Category: HIV Vaccines
- Published on Monday, 11 April 2011 23:09
- Written by UC Davis
Researchers have identified how the HIV envelope changes shape after binding to a host cell, exposing conserved proteins that might be good targets for a vaccine.
Global HIV Vaccine Enterprise Publishes Plan to Expand Research
- Details
- Category: HIV Vaccines
- Published on Friday, 10 September 2010 14:17
- Written by Global HIV Vaccine
The Global HIV Vaccine Enterprise -- an alliance of researchers, advocates, and funding sources around the world dedicated to accelerating development of a preventive HIV vaccine -- this week released a new plan for faster and more efficient research. The Enterprise Scientific Strategic Plan, published in the September 2010 issue of Nature Medicine, aims to translate recent advances in the field into "faster, smarter and more productive" vaccine research.
More Articles...
- Experts Call for 'New Era' of Unified HIV Vaccine Research
- Researchers Discover Broadly Neutralizing Antibodies that Act Against 91% of HIV Strains
- Scientists at the U.S. National Institutes of Health Discover Human Antibodies That Can Stop Most HIV Strains from Infecting Human Cells
- Additional ALVAC/AIDSVAX HIV Vaccine Data Show Only Modest Benefit with Minimal Statistical Significance
Web Design and Development by